Abstract: Phytochemical investigation of the heartwood of Michelia compressa afforded forty-four compounds, which were identified by comparison of experimental and literature analytical and spectroscopic data. Some compounds were evaluated for their anti-inflammatory and anticancer bioactivities. The result showed that soemerine (1) and cyathisterol (2) exhibited significant nitric oxide (NO) inhibition, with IC 50 values of 8.5 ± 0.3 and 9.6 ± 0.5 µg/mL, respectively. In addition, liriodenine (3) and oliveroline (4) exhibited cytotoxicity to human nasopharyngeal carcinoma (NPC-TW01), non-small cell lung carcinoma (NCI-H226), T cell leukemia (Jurkat), renal carcinoma (A498), lung carcinoma (A549) and fibrosarcoma (HT1080) cell lines with IC 50 values in the range of 15.7-3.68 μM.
Introduction
Michelia (Magnoliaceae) consists of about 30 species, living in subtropical and tropical Asia, from eastern India through the Indo-Chinese Peninsula to Southern China, Southern Japan and southward to Malay Islands. One species is native to Taiwan [1] . Michelia species have been used in the treatment of cancer by indigenous peoples. Such as, Michelia champaca has been used in India for the treatment of abdominal tumors as well as Michelia hypoleuca and Michelia officinalis for carcinomatous sores and leukemia respectively, in China. Experimentally, Michelia grandiflora, Michelia compressa and Michelia kobus have proven anticancer activity in various tumor systems [2] . In addition, the extract of Michelia champaca leaves has also exhibited an anti-inflammatory activity in pro-inflammatory conditions [3] . Moreover, the aporphine alkaloid and sesquiterpene lactone constituents of this genus have caused a great interest due to their diverse structures and significant biological activities [2] [3] [4] [5] [6] .
Michelia compressa var. formosana is an evergreen tree mainly distributed in Taiwan, Japan, and Ryukyu Islands [1] . In the previous literature, its heartwood exhibited high resistance against rots due to the presence of liriodenine [6] . The chemical investigations of leaves [5, 7] , barks [8] , root barks [2] , root wood [4] , heartwood [9, 10] , stems [11] , and pericarps [12] have been reported, but the anti-inflammatory and cytotoxic properties of constituents from heartwood are not known.
In our future research, we focus on the identification of anticancer and anti-inflammatory drug leads from natural sources. In our research, the bioactive constituents of the heartwood of M. compressa were searched for by assaying the effects on nitric oxide (NO) inhibition in LPS (lipopolysaccharide)-activated mouse peritoneal macrophages and evaluating their cytotoxicity of six human cancer cell lines including human nasopharyngeal carcinoma (NPC-TW01), non-small cell lung carcinoma (NCI-H226), T cell leukemia (Jurkat), renal carcinoma (A498), lung carcinoma (A549) and fibrosarcoma (HT1080) cell lines.
Results and Discussion

Isolation and Characterization of Compounds
Air-dried and powdered heartwood of M. compressa var. formosana was soaked with ethanol at room temperature, and the combined extracts were concentrated to give a deep brown syrup. The crude extract was suspended into water and partitioned with CHCl 3 to afford CHCl 3 layer and water solubles, respectively. Purification of the CHCl 3 soluble fraction by column chromatography yielded roemerine (1, 13.7 mg) [13] , cyathisterol (2, 10.8 mg) [14] , liriodenine (3, 379 mg) [10] , oliveroline (4, 2.1 mg) [15] , ushisurine (5, 230 mg) [10] , dihydrocostunolide (6, 3.6 mg) [16] , (−)-N-formylanonaline (7, 7.9 mg) [15] , 6α-hydroxy-β-sitostenone (8, 4.7 mg) [15] , ferulic acid (9, 5.9 mg) [17] , β-sitosterone (10, 10.3 mg) [18] , β-stigmastenone (11, 11.5 mg) [18] , costunolide (12, 1.2 mg) [19] , β-sitostanone (13, 1.6 mg) [18] , dehydroroemerine (14, 1.9 mg) [20] , ferruginol (15, 1.2 mg) [21] , sugiol (16, 1.3 mg) [22] , ( 11 S)-1-oxoedudesm-4(14)-eno-13, 6α-lactone (17, 1.1 mg) [23] , dihydroreynosin (18, 1.2 mg) [23] , romucosine (19, 1.6 mg) [24] , 11,13-dihydrosantamarin (20, 0.8 mg) [25] , 2-methylanthraquinone (21, 1.5 mg) [26] , methyl 22-feruloyloxydocosanoate (22, 1.9 mg) [27] , annonbraine (23, 1.1 mg) [28] , ferulic aldehyde (24, 0.7 mg) [29] , secoroemerine (25, 0.6 mg) [30] , blumenol A (26, 1.3 mg) [31] , (−)-N-formyldehydroanonaline (27, 1.7 mg) [32] , 6α,7-dehydroanonaline (28, 0.9 mg) [33] , N-transferuloyltyramine (29, 1.0 mg) [27] , N-trans-feruloylmethoxytyramine (30, 1.1 mg) [17] , syringaresinol (31, 1.7 mg) [34] , cepharadione-A (32, 0.9 mg) [35] , aristolic acid II (33, 0.8 mg) [17] , O-acetyl-ushinsunin (34, 0.9 mg) [10] , (+)-isolaricirensinol (35, 1.6 mg) [34] , northalifoline (36, 1.5 mg) [35] , cassyformin (37, 2.0 mg) [36] , 3-[2-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propan-1-ol (38, 1.7 mg) [37] , dehydrodiconiferyl alcohol (39, 0.8 mg) [38] , divanillyl tetrahydrofuran (40, 1.9 mg) [39] , methyl vanillate (41, 0.7 mg) [24] , noroliveroline (42, 0.7 mg) [40] , 1-acetyl-β-carboline (43, 1.6 mg) [41] and trans-feruloyloxyhexacosanoic acid (44, 2.3 mg) [42] , and their structures were identified by comparison of their physical and spectroscopic data with those reported in the literature.
Inhibitory Effects of Isolated Compounds on Nitric Oxide (NO) Production
The isolated compounds (1-3, 5, 7, 9-11) were subjected into the examination of their effects on LPS-induced NO production in murine RAW 264.7 macrophage cell line. RAW 264.7 cells were incubated with various concentrations of these compounds and LPS (100 ng/mL) for 24 h for detection of NO production. NO plays a role as neurotransmitter, vasodilator, and immune regulator in a variety of tissues at physiological concentration. High levels of NO produced by inducible nitric oxide synthase (iNOS) have been defined as a cytotoxic molecule in inflammatory process [43] . After 24 h incubation, the culture medium of non-LPS treated macrophages was used as background levels of nitrite. Nitrite accumulated in the culture medium was estimated by the Griess reaction as an index for NO release from the cells. In the present study, NO production was significantly decreased by the treatment with roemerine (1) and cyathisterol (2) (Figure 1 ) in a dose-dependent manner, with IC 50 values of 8.5 ± 0.3 and 9.6 ± 0.5 µg/mL, respectively (Table 1 ). 
Anticancer Bioactivities of Isolated Compounds
To assess the growth inhibitory activity of the isolated compounds 1-11 toward cancer cells, six different cell lines from malignant tumors including human nasopharyngeal carcinoma (NPC-TW01), non-small cell lung carcinoma (NCI-H226), T cell leukemia (Jurkat), renal carcinoma (A498), lung carcinoma (A549) and fibrosarcoma (HT1080) cell lines were used. The result showed that liriodenine (3) and oliveroline (4) (Figure 1 ) treatment exhibited inhibition of human cancer cell lines with IC 50 values in the range of 15.7-3.68 μM (Table 2) . Moreover, liriodenine (3) and oliveroline (4) exhibited the powerful inhibitory activity against renal carcinoma (A498) with IC 50 valuses 4.52 and 3.68 μM, respectively. Our study suggests the heartwood of M. compressa var. formosana and its isolates could be viewed as potential candidates for the development of anti-cancer drugs. 
Experimental Section
General Procedures
UV spectra were obtained with a Hitachi UV-3210 spectrophotometer (Hitachi, Tokyo, Japan), and IR spectra were recorded on a Shimadzu Fourier transform infrared spectroscopy (FT-IR) DR-8011 spectrophotometer spectrophotometer (Olympus, Tokyo, Japan). Optical rotations were measured with a JASCO P-2000 digital polarimeter in a 0.5 dm cell. The electrospray ionization mass spectrometry (ESI-MS, Bruker, Bremen, Germany) and high resolution electrospray ionization mass spectroscopy (HRESI-MS, Bruker, Bremen, Germany) were taken on a Bruker Daltonics APEX II 30e spectrometer (Bruker, Bremen, Germany). The 1 H and 13 C nuclear magnetic resonance spectroscopy ( 1 H and 13 C NMR) spectra were measured using Bruker Avance-300 (Bruker Biospin Inc., Ettlingen, Germany), AMX-400 (Bruker Biospin Inc., Ettlingen, Germany), and AV-500 spectrometers (Bruker Biospin Inc., Ettlingen, Germany) with tetramethylsilane (TMS) as the internal reference, and chemical shifts are expressed in δ (ppm). Silica gel (70-230 and 230-400 mesh; Merck KGaA, Darmstadt, Germany) and Spherical C18 reversed phase silica gel (RP-18; particle size 20-40 μm; Silicycle, Quebec City, QC, Canada) were used for column chromatography (CC), and silica gel 60 F254 (Merck, Darmstadt, Germany) and RP-18 F254S (Merck) were used for thin layer chromatography (TLC) and preparative TLC, respectively.
Plant Materials
The heartwood of M. compressa var. formosana (Magnoliaceae) was collected from Taipei Hsien, Taiwan, in June 2012 and verified by Prof. Kuoh, C.-S. A voucher specimen (TSWu-2012006) has been deposited in the Herbarium of National Cheng Kung University, Tainan, Taiwan.
Extraction and Isolation
The heartwood of M. compressa var. formosana (10 kg) was air-dried and powdered and soaked (24 h) three times with 20 L ethanol at room temperature, and the combined extracts were concentrated under reduced pressure to give deep brown syrup (720 g). The crude extract was suspended into water (1 L) and partitioned five times with 1 L CHCl 3 to afford CHCl 3 layer (245 g) and water solubles (462 g), respectively, after removal of the corresponding solvent.
The CHCl 3 soluble extracts were purified by silica gel column chromatography eluted with CHCl 3 and MeOH gradients to afford 7 fractions. Fraction 2 was subjected to silica gel column chromatography eluted with n-hexane/acetone (25:1) to yield 2, 5, 6, 10-21, and 43. Purification of fraction 4 by column chromatography with silica gel was eluted by step gradients of n-hexane/acetone (15:1 and 9:1) to afford 7 and 22-24. Fraction 5 was subjected to silica gel column chromatography eluted with n-hexane/acetone (15:1) to yield 3, 8, 25-33 , and 44. Separation of fraction 7 by column chromatography with silica gel eluted by n-hexane/acetone (7:1) yielded 1, 4, 9, and 34-42. 1-3, 5, 7, 9-11 ) in the presence of LPS (100 ng/mL) for 24 h. Cells were washed twice with DPBS and incubated with MTT (100 µL, 0.5 mg/mL) for 2 h to analyze cell viability. The medium was discarded and dimethyl sulfoxide (DMSO) (100 µL) was added. After 0.5 h incubation, absorbance at 570 nm was read using a microplate reader (Molecular Devices, Orleans Drive, Sunnyvale, CA, USA).
Determination of Inhibitory Effects on NO Production
Measurement of Nitric Oxide/Nitrite
The presence of nitrite (a metabolite of NO) in the culture medium was analyzed with the Griess assay (Sigma-Aldrich) as described previously [44] . Briefly, cells cultured in 96-well plates were treated with compounds in the presence of LPS (100 ng/mL) at 37 °C for 24 h, and cultured supernatant (100 μL) was mixed with the same volume of Griess reagent (1% sulfanilamide, 0.1% naphthyl ethylenediamine dihydrochloride and 5% phosphoric acid). After incubation at room temperature for 10 min, the absorbance was measured at 540 nm with a Micro-Reader (Molecular Devices, Orleans Drive, Sunnyvale, CA, USA). Serum samples from mice were diluted four times with distilled water and deproteinized by adding 1/20 volume of zinc sulfate (300 g/L) to a final concentration of 15 g/L. After centrifugation at 10,000× g for 5 min, 100 μL supernatant was applied to a microtiter plate well, followed by adding 100 μL of Griess reagent. After 10 min of color development, the absorbance was measured at 540 nm. Various concentrations of sodium nitrite were used to perform a standard curve.
Statistical Analysis
Experimental results were presented as the mean ± standard deviation (SD) of three parallel measurements. Statistical evaluation was carried out by one-way analysis of variance (ANOVA followed by Scheffe's multiple range tests). Statistical significance is expressed as * p < 0.05, ** p < 0.01 and *** p < 0.001.
Determination of the Anticancer Bioactivity
Cell Lines
Human cancer cell lines, including T cell leukemia (Jurkat); non-small cell lung carcinoma (NCI-H226), renal carcinoma (A498), lung carcinoma (A549) and fibrosarcoma (HT1080) were obtained from the American Type Culture Collection (Rockville, MD, USA). A nasopharyngeal carcinoma (NPC-TW01) cell line was purchased from Food Industry Research and Development Institute (Hsinchu, Taiwan). Tumor cells were maintained in proper medium supplemented with 10% fetal bovine serum (FBS) at 37 °C in a humidified atmosphere of 5% CO 2 .
Growth Inhibition Assay
The evaluation of cell growth and survival was carried out according to Hansen et al. [45] with modification. Briefly, cells were seeded in a 96-well plates and incubated overnight prior to the addition of the designated compounds at various concentrations for three subculture. Two hours before end of treatment, 15 μL of MTT solution (5 mg/mL) was added to each well, and the cells were incubated at 37 °C for 4 h. Subsequently 75 μL lysis buffer (20% SDS-50% N,N-dimethyl formamide) was added to each well, and the culture plate was incubated at 37 °C overnight to dissolve the dark blue crystals. The conversion to formazan by metabolically viable cells was measured by absorbance at 570 nm. The percentage of conversion by control cells was used to evaluate the effect of the compounds on cell growth and to determine the IC 50 values.
Conclusions
In summary, forty-four compounds were characterized from the heartwood of Michelia compressa var. formosana. Furthermore, the inhibitory activity on LPS-induced NO production in RAW 264.7 cells and the cytotoxicity on six cancer cells were analyzed. These results provide a potential explanation for the usage of the heartwood of M. compressa as the herbal medicine in the treatment of cancer diseases, and they may be potentially useful in developing new anticancer agents.
